Why the Sirtex Medical Limited share price is climbing higher today

The Sirtex Medical Limited (ASX:SRX) share price is higher today on Federal Court news.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sirtex Medical Limited (ASX: SRX) share price opened 2% higher at $12.11 this morning after the cancer treatment specialist announced that a Federal Court application to have its on-market share buyback postponed was dismissed.

This is good news for the company and its capital management plans as the healthcare specialist has an extremely strong balance sheet with no debt and around $100 million in cash on hand as at the end of December 31 2016.

Arguably, Sirtex also has an undervalued share price after investors reacted badly to a series of disappointing clinical trial results that all but ruled out the possibility of its flagship SIR-Spheres treatment being more widely used by oncologists in the treatment of different cancers.

The Federal Court application had been filed by a little-known team of Melbourne lawyers who at the end of 2016 also announced they would be chasing compensation from Sirtex on behalf of a single named shareholder over its recent market announcements.

Sirtex aslo recently fired its chief executive as a result of an internal investigation into his share selling over the second half of 2016 and has recently appointed a new full time CEO.

Although, today's news that the company is free to commence its buy-back is a positive it does not mean it will escape the already announced claim and a possibly wider class action from shareholders upset over the December 2016 downgrade to dose sales forecasts. In that sense it could still be facing a decent sized compensation bill.

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »